- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALK Negative NSCLC
Total 438267 results
-
Celldex TherapeuticsNo longer availableMetastatic gpNMB Expressing Triple Negative Breast Cancer
-
Instituto Nacional de Cancer, BrazilDana-Farber Cancer InstituteCompletedTriple Negative Breast Cancer Patients
-
Chen SuningRecruitingALL, Adult | Philadelphia-Negative ALLChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingNSCLC Stage IV | ALK Fusion Protein ExpressionUnited States
-
George T. BuddUnited States Department of Defense; Anixa Biosciences, Inc.RecruitingResidual Disease | TNBC - Triple-Negative Breast Cancer | Pathologic Stage IIA-IIIC Triple-Negative Breast CancerUnited States
-
Institut de cancérologie Strasbourg EuropeCentre de recherche du Centre hospitalier universitaire de SherbrookeRecruitingTriple-negative Breast CancerFrance
-
Merck Sharp & Dohme LLCRecruitingTriple-Negative Breast CancerUnited States
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
First Affiliated Hospital Bengbu Medical CollegeRecruitingTriple-negative Breast CancerChina
-
Sichuan Provincial People's HospitalRecruitingTriple-negative Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingTriple-negative Breast CancerChina
-
Texas Tech University Health Sciences Center, El...RecruitingTriple-negative Breast CancerUnited States
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Argentina, Chile, Hungary, Mexico, Peru, Poland
-
Laura KennedyNational Cancer Institute (NCI)SuspendedBreast Cancer | Triple-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdCompletedTriple-negative Breast CancerChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...University of Milan; European Institute of Oncology; IFOM, The FIRC Institute...Active, not recruitingTriple-negative Breast CancerItaly
-
Guangdong Provincial People's HospitalCompletedTriple-Negative Breast CancerChina
-
Fudan UniversityActive, not recruiting
-
Universitaire Ziekenhuizen KU LeuvenCompletedBreast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative NeoplasmBelgium
-
Tianjin Medical University Cancer Institute and...UnknownTriple-negative Breast CancerChina
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.TerminatedTriple Negative Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Negative Breast CancerUnited States
-
ETOP IBCSG Partners FoundationMirati Therapeutics Inc.RecruitingNSCLC Stage IV | KRAS P.G12CIreland, Italy, France, Spain, United Kingdom, Belgium
-
Palobiofarma SLOhio State UniversityActive, not recruiting
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Jun Zhang, MD, PhDNilogen OncosystemsRecruitingNSCLC | Lung Cancer | NSCLC Stage IVUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCChina
-
Novartis PharmaceuticalsTerminatedOvarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Colorectal Cancer Microsatellite Stable (MSS)Canada, Australia, Singapore, United States, Japan, Spain, United Kingdom
-
PfizerTerminatedNeoplasms | Triple-Negative Breast CancerUnited States
-
Harbin Medical UniversityJiangsu HengRui Medicine Co., Ltd.Unknown
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisAstraZenecaRecruitingEarly Small (cT1N0) Triple Negative Breast CancerFrance
-
Huihua XiongRecruiting
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC; G1 Therapeutics, Inc.RecruitingMetastatic Triple-Negative Breast CancerUnited States
-
Ministry of Health, Saudi ArabiaMaher M.aklNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
First Affiliated Hospital of Shantou University...Guangdong ProCapZoom Biosciences Co., Ltd.Not yet recruitingAdvanced Triple Negative Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer
-
Fundacio Clinic BarcelonaSOLTI Breast Cancer Research GroupNot yet recruitingMetastatic Triple-Negative Breast CarcinomaSpain
-
OncoPep, Inc.Not yet recruitingMetastatic Triple-Negative Breast Carcinoma
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Fudan UniversityActive, not recruitingTNBC - Triple-Negative Breast CancerChina
-
The Methodist Hospital Research InstituteCompletedMetastatic Triple Negative Breast CancerUnited States
-
Fudan UniversityCompletedAdvanced Triple-Negative Breast CancerChina
-
AHS Cancer Control AlbertaTom Baker Cancer CentreWithdrawnMetastatic Triple Negative Breast CancerCanada
-
Russian Academy of Medical SciencesCompletedEarly Triple Negative Breast CancerRussian Federation
-
Astellas Pharma Global Development, Inc.WithdrawnSubjects With NSCLC With an EGFR Activating Mutation